English
Home > Products > CAS NO 79538-20-8

China CAS NO 79538-20-8 Factory

"Sincerity, Innovation, Rigorousness, and Efficiency" is the persistent conception of our firm for the long-term to create jointly with consumers for mutual reciprocity and mutual reward for CAS NO 79538-20-8,79538-20-8,3,5-Difluorobenzyl alcohol, Being a young escalating company, we might not the top, but we're trying our best to generally be your superior partner.
CAS NO 79538-20-8, Our company has a skillful sales team, strong economic foundation, great technical force, advanced equipment, complete testing means, and excellent after-sales services. Our goods have beautiful appearance, fine workmanship and superior quality and win the unanimous approvals of the customers all over the world.

Related Products

Hot Products

  • Pazufloxacin mesilate

    Pazufloxacin mesilate

    Product Name:Pazufloxacin mesilate
    Molecular Formula:C17H19FN2O7S
    Molecular Weight;414.4053632
    CAS Registry Number;163680-77-1
  • 2,3,4-Trifluorobenzenamine

    2,3,4-Trifluorobenzenamine

    Product Name:2,3,4-Trifluorobenzenamine
    Molecular Formula:C6H4F3N
    Molecular Weight:147.1
    CAS Registry Number:3862-73-5
  • Crisaborole

    Crisaborole

    Product Name:Crisaborole
    Molecular Formula:C14H10BNO3
    Molecular Weight;251.05
    CAS Registry Number;906673-24-3
  • Z-LYS(Z)-OH

    Z-LYS(Z)-OH

    Product Name:Z-LYS(Z)-OH
    Molecular Formula:C22H26N2O6
    Molecular Weight:414.45
    CAS Registry Number:405-39-0
  • Cetrorelix acetate

    Cetrorelix acetate

    Product Name:Cetrorelix acetate
    Molecular Formula:C70H92ClN17O14
    Molecular Weight;1431.04
    CAS Registry Number;120287-85-6/130143-01-0
  • (R)-(-)-3-Hydroxytetrahydrofuran

    (R)-(-)-3-Hydroxytetrahydrofuran

    Product Name:(R)-(-)-3-Hydroxytetrahydrofuran
    Molecular Formula:C4H8O2
    Molecular Weight:88.11
    CAS Registry Number:86087-24-3
  • Related Blog
  • Reviews

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • What Is Misoprostol Used For?

    Misoprostol, a derivative of prostaglandin E1, can be used in the treatment of duodenal ulcer, the prevention of anti-inflammatory induced peptic ulcer and the prevention of early pregnancy.It has the function of inhibiting the secretion of gastric acid and preventing the formation of ulcer, thus protecting the gastric mucosa...

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept